Loading clinical trials...
Loading clinical trials...
A Feasibility Study of Interim PET-MRI in High-grade Glioma Patients Undergoing Chemoradiation
Conditions
Interventions
PET-MRI Brain Scan
Blood draw
+2 more
Locations
1
United States
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
Start Date
September 2, 2022
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
March 23, 2026
NCT03340506
NCT05278208
NCT05839379
NCT04655404
NCT07042620
NCT06428045
Lead Sponsor
Wake Forest University Health Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions